- alias::
  ICD-11_Code::
  tags:: #Disease
- ## Etiology
  background-color:: blue
  - ### Causative Agents
  - ### Risk Factors
- ## Epidemiology
  background-color:: blue
  - ### Incidence
  - ### Prevalence
    - ### Demographics
  - ### Geographic Distribution
- ## Pathophysiology
  background-color:: blue
  - ### Mechanism of Disease
  - ### Affected Systems/Organs
- ## Clinical Features
  background-color:: blue
  - ### Clinical Presentation
    - #### Symptoms
    - #### Signs
  - ### Stages or Classification
  - ### Diagnostic Criteria
- ## Diagnosis
  background-color:: blue
  - ### Clinical Diagnosis
    - #### Classical Presentation
    - #### Probable Diagnosis
  - ### Laboratory Tests
  - ### Imaging Studies
  - ### Differential Diagnosis
  - ### Confirmation of Diagnosis
- ## Management and Treatment
  background-color:: blue
  - ### Medical Treatment
    - [[Atropine 1% Sulphate]]
      - Reason #eye-prof-card #card
        deck:: #Eye
        id:: 67541e08-11bf-4d94-8ab7-cff391949cc8
        - **Reduces ciliary muscle spasm**: By inducing **cycloplegia**, atropine alleviates **pain** associated with ciliary muscle spasm.
        - **Keeps the pupil fixed and dilated**: Atropine induces **mydriasis**, preventing further angle closure and reducing the risk of complications from **neovascularization** of the iris (rubeosis iridis).
  - ### Surgical Options
  - ### Lifestyle and Dietary Recommendations
  - ### Follow-up
- ## Prognosis
  background-color:: blue
  - ### Expected Course
    - #### With Treatment
    - #### Without Treatment
      - ##### Possible Complications
      - ##### Long-Term Effects
  - ### Survival Rates
    - #### With Treatment
    - #### Without Treatment
  - ### Quality of Life Considerations
- ## Prevention
  background-color:: blue
  - ### Health Education
  - ### Community Approach
  - ### Screening Programs
  - ### Lifestyle Modifications
- ## Patient Education and Support
  background-color:: blue
  - ### Educational Resources
  - ### Support Groups
  - ### Counseling Options
- ## Recent Research and Developments
  background-color:: blue
  - ### Ongoing Clinical Trials
  - ### Recent Advances
- ## Key Literature
  background-color:: blue
- ## Guidelines and Protocols
  background-color:: blue
